Yüklüyor......
SA-4-1BBL/MPL as a novel immune adjuvant platform to combat cancer
Practical experience with cancer vaccines combined with accumulated knowledge of the complex interactions between cancer and immune system rationalize the combinatorial use of immune adjuvants for better efficacy. We recently described a novel adjuvant system based on the costimulatory SA-4-1BBL and...
Kaydedildi:
| Yayımlandı: | Oncoimmunology |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4760279/ https://ncbi.nlm.nih.gov/pubmed/26942082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1064580 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|